Hubert Chen, MD
Dr. Hubert Chen, Chief Medical Officer at ADARx Pharmaceuticals
Hubert C. Chen, MD is the Chief Medical Officer of Metacrine Inc., a clinical-stage biopharmaceutical company focusing on innovative drugs to treat liver and gastrointestinal diseases. Previously, he served as the Chief Medical & Scientific Officer of Pfenex Inc., a company focusing on biosimilars and therapeutic equivalent peptides. In that capacity, Dr. Chen oversaw all research and development activities – including analytical, preclinical, clinical, regulatory, process and product development – in ophthalmology, osteoporosis, neutropenia, multiple sclerosis, and anthrax infection. He also represented Pfenex in multiple interactions with the US FDA, EMA and Japan PMDA.